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In this paper, we show how we have applied the Clinical Narrative Temporal Relation Ontology (CNTRO) and its
associated temporal reasoning system (the CNTRO Timeline Library) to trend temporal information within medical
device adverse event report narratives. 238 narratives documenting occurrences of late stent thrombosis adverse
events from the Food and Drug Administration’s (FDA) Manufacturing and User Facility Device Experience (MAUDE)
database were annotated and evaluated using the CNTRO Timeline Library to identify, order, and calculate the
duration of temporal events. The CNTRO Timeline Library had a 95% accuracy in correctly ordering events within
the 238 narratives. 41 narratives included an event in which the duration was documented, and the CNTRO
Timeline Library had an 80% accuracy in correctly determining these durations. 77 narratives included documentation
of a duration between events, and the CNTRO Timeline Library had a 76% accuracy in determining these durations.
This paper also includes an example of how this temporal output from the CNTRO ontology can be used to verify
recommendations for length of drug administration, and proposes that these same tools could be applied to other
medical device adverse event narratives in order to identify currently unknown temporal trends.Introduction
The Clinical Narrative Temporal Relation Ontology
(CNTRO) [1] and its associated temporal reasoning
framework (CNTRO Timeline Library) [2,3] can be used
to facilitate an efficient and semi-automated temporal
analysis of events documented within a narrative. Previ-
ously it has been shown how CNTRO can be combined
with LifeFlow [4] software developed by the University
of Maryland, which is capable of visualizing event se-
quences, such that it is possible to see patterns in the
order of events within several narratives [5]. CNTRO’s
ability to correctly answer temporal-related questions re-
garding specific events that have occurred within a nar-
rative has also been previously demonstrated [6]. The
goal of this present paper is to illustrate how CNTRO
(referring to both the ontology and its associated Time-
line Library) can be used to analyze temporal properties
of events documented across multiple narratives. In this* Correspondence: cui.tao@uth.tmc.edu
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The Food and Drug Administration (FDA) requires
notification of all medical device adverse events that are
associated with malfunction, serious injury, or death [7].
Events leading up to the device failure are compiled and
reported within a narrative text, which is made publi-
cally available through the MAUDE (Manufacturer and
User Facility Device Experience) database [8,9]. Analysts
at the Center for Devices and Radiological Health (CDRH)
read the event histories of each narrative to identify poten-
tial trends that may exist, which includes temporal pat-
terns (similar sequences of events, similar durations of or
between events, similar time/date stamps of event occur-
rences, etc.) [10]. However with 80,000 to 120,000 device-
related adverse events reported annually to the FDA [11],
this approach to trend identification is time consuming,
expensive, and the potential exists for a missed trend iden-
tification. An automated temporal analysis of adverse
event narratives would lead to faster identification of pat-
terns and/or earlier prediction of a future failure, which
could be used to drive improvements into the next gener-
ation of medical devices.
Automating temporal analysis of events within a narra-
tive is a complex problem. A computer program cannotd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tions by querying information directly from a narrative
without semantic annotation and inference. Human ex-
perts can understand temporal relationships through the
use of words such as “before”, “after”, “during”, “follow-
ing”, etc. and appreciate that 1 year, 12 months, and 365
days are approximately equivalent even though differences
in granularity are used. To allow for a “machine-under-
standable” data representation and exchange of temporal
information automatically, the CNTRO System uses a
Semantic-Web [12] based framework to apply relation-
ships between events within natural language narratives
through the use of the RDF (Resource Description Frame-
work) triple representation [1]. An RDF triple consists of a
subject, an object, and a predicate, which indicates the re-
lationship between the subject and the object [10].
Consider the following example. “60 days after stent
implantation, antiplatelet therapy was discontinued in
preparation for a splenectomy surgery.” In this example,
stent implantation is identified as the subject, antiplate-
let therapy discontinuation is identified as the object,
and “after” is identified as the predicate. A temporal re-
lationship is created between stent implantation and dis-
continuation of antiplatelet therapy using a temporal
offset of 60 days.
The computer program now “understands” that stent
implantation occurred first, and discontinuation of anti-
platelet therapy occurred second. It also “understands”
that the time delay between these two events was 60
days. Additionally, there is an inference that because an-
tiplatelet therapy was stopped, it had to have started at
some point prior. The CNTRO framework then creates
a timeline for events and provides a programmatic query
interface to access the timeline information. This makes
it possible for the time-related information to now be
queried in an automated manner. In our particular ex-
ample, we could ask questions such as: Which event oc-
curred first? How long after stent implantation was
antiplatelet therapy administration discontinued?
Many previous efforts have been attempted to model
temporal information within computer-based systems.
Ontologies such as Time ontology [13] and the SWRL
Temporal ontology [14] can formally model temporal in-
formation in general and connect with semantic rea-
soners for inferring new temporal relations based on
semantics defined within the ontologies. These ontol-
ogies only focus on structured data with absolute time
information, however, and therefore cannot precisely
capture the temporal information expressed in human
language [1]. In clinical narratives, many temporal fea-
tures are expressed in relative (e.g. next Friday) or am-
biguous (e.g. early last week) ways. Ignoring this data
will forgo valuable information that could be otherwise
leveraged in clinical research. Models such as the HL7time specification [15] and the TimeML model [16] offer
a way to represent temporal information form semi-
structured or unstructured narratives. These approaches,
however, do not provide the formal semantic definition
capacities for domain knowledge as ontologies do. In
clinical narratives, temporal information is often not ex-
plicitly expressed, but rather needs to be inferred before
the data can be further analyzed. Without a reasoning
component, it is difficult to resolve a relatively complete
patient history for profound clinical studies [17]. There-
fore, we believe that the CNTRO system is necessary as
it provides a formal ontology in OWL with well-defined
semantics for the time domain and enables semantic-
web [12] based temporal reasoning.
Methods
The CNTRO system
CNTRO [1] is an OWL ontology designed to model
temporal relations among clinical events. Figure 1 shows
the ontology overview. It models clinical events, tem-
poral entities (including time instants, time intervals, re-
peated time periods, and durations), time granularity
(minute, hour, day, month, year), temporal relationships,
and time uncertainties in the semantic web notation. In
order for users to annotate events and time-related in-
formation using CNTRO semantics, a Protégé plug-in,
Semantator [18], was developed to interface with CNTRO’s
temporal reasoning framework. Semantator provides users
two modes: manual annotation mode and semi-automatic
annotation mode. In the manual annotation mode, the
users can view the domain ontology, the document to be
annotated, and the annotated result in the same environ-
ment. For semi-automatic annotation, we have linked
Semantator with Natural Language Processing tools that
support automatic named entity recognition. Users can
browse, revise, and save the annotation results at anytime.
Semantator has been used to create gold standard annota-
tions for evaluating the reasoning output in our project.
The annotated information is stored as an OWL/RDF file
or an RDF triple. The CNTRO Timeline Library is then
used to infer temporal information not explicitly expressed
in the original narrative [2]. The CNTRO Timeline Library
contains a rule-based normalizer that automatically con-
verts different temporal expressions into standard formats
such as the XML dateTime format. It also leverages the se-
mantic definitions in the ontology (e.g. OWL DL axioms,
property transitivity and inversions) to support temporal
relation inference. These OWL features were handled by
the Pellet OWL reasoner. In addition, the Timeline Li-
brary contains a set of Java functions for answering a list
of time-related questions, such as when a particular event
happened, chronological sequence of events, durations of
events, durations between events, temporal relations be-
tween events, and sorting a set of events on the timeline.
Figure 1 CNTRO overview.
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temporal relations. It then considers all the temporal rela-
tions among the events, normalized timestamps of the
events, and durations of the events to compute new time
stamps of events if possible. It can also calculate the dur-
ation of an event given the start and end time of the event
and the duration between two events given the time
stamps of them. After all the possible inferences and cal-
culations are done, it tries to sort a given set of events
based on all the above information.
Late stent thrombosis adverse event identification
Late Stent Thrombosis (LST) adverse event narratives
were used to demonstrate how the CNTRO system and
its automated temporal relation reasoning can be used
to verify drug therapy duration recommendations. Al-
though the exact mechanism or mechanisms of LST are
not known, it has been observed to occur less frequently
when dual antiplatelet therapy has been administered
over a period of time [19,20]. Current guidelines recom-
mend the administration of dual antiplatelet therapy for
3 to 6 months following drug-eluting stent implantation,
unless the patient is not at high risk for bleeding, in
which case therapy is recommended for 12 months [21].
The CNTRO System was used to evaluate the order of
events within each narrative and query both the duration
in which antiplatelet therapy was administered and the
duration between initial stent implantation and the oc-
currence of late stent thrombosis.
Narratives used in this study were obtained from med-
ical device adverse event reports documented within the
MAUDE database. 238 adverse event reports were iden-
tified in which late stent thrombosis occurred, defined
either as “late” within the report or by a duration of 6
months between stent implantation and the occurrenceof thrombosis. These narratives were then manually an-
notated using Semantator by an expert.
Adverse event narrative annotation
We created a domain ontology which includes common
events that occur after stent implantation was created
with specific normalized event types. The domain ontol-
ogy is relative to simple comparing to the CNTRO. It
only defines the set of events we what to monitor for
our use case. These events were then imported into
CNTRO for temporal relationship modeling. The follow-
ing events were included: initial stent implantation, fol-
low up stent implantation(s), start and stop time points
of antiplatelet therapy administration, unrelated surger-
ies occurring after stent implantation, late stent throm-
bosis, myocardial infarction, admission to the emergency
room, and patient death. Events such as guide wire in-
sertion are required for all stenting procedures; therefore
annotation of these events would not be beneficial and
were therefore not performed. Life-saving events follow-
ing the thrombosis detection were also not annotated
within the narratives as the focus of the application of
CNTRO was based on verifying the recommended dur-
ation of drug administration and not the potential to
survive following an occurrence of thrombosis.
Start and stop point of the antiplatelet therapy were an-
notated to determine the duration of therapy. Unrelated
surgeries which occurred between stent implantation and
identification of thrombosis, myocardial infarction, ad-
mission to the emergency room and patient death were
all annotated as events to verify the Event Order and In-
ferred Relationship functions of the CNTRO Timeline
Library.
Annotations were performed using Semantator. The
first step in the annotation process involves identification
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event is created, the text turns color specific to each event
type.
After the events are created, temporal relationships be-
tween the events can be defined through annotation, see
Figure 3. A relationship connects two events and can indi-
cate that the events occurred or began at the same time,
or that one event occurred or began before another event.
If the duration between the events is known, this is anno-
tated after the relationship has been defined, see Figure 3.
If a specific event has a duration, this information is anno-
tated as well.
CNTRO timeline evaluation
For each annotated narrative, the CNTRO Timeline Li-
brary creates a matrix that visually shows the temporal
relationships between the events, which is a simple way
to track, view, document, and evaluate the accuracy of
CNTRO system timeline computations. Each annotatedFigure 2 Annotating an event.event is included within the matrix. The matrix indicates
which events occur at the same time, and then orders
the remaining events on a timeline as applicable. Figure 4
shows a sample matrix. Figure 4(a) shows a partial com-
plaint file with three events and their corresponding tem-
poral constraints highlighted. Figure 4(b) shows the event
descriptions. Figure 4(c) shows the annotated (asserted)
temporal relations between events (e.g., EVENTID-3
EQUAL EVENTID-1). Figure 4(d) shows both asserted
and inferred temporal relations between events. Based on
the annotation result, the reasoner knows the timestamp
of EVENTID-1 and EVENTID-3 as well as the fact that
EVENTID-3 and EVENTID-1 happened at the same
time. It can therefore infer the timestamp of EVENTID-3
which is the same as the one for EVENTID-1. Then
based on the timestamps, it can infer the temporal rela-
tions among the three events. Finally Figure 4(e) shows
the timeline bucket that includes a set of sorted timeline
entries.
Figure 3 Annotating a relationship.
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Event Narratives were reviewed using these matrices and
compared against gold standard results, in which events
were manually recorded in timeline order from two ex-
ports reading each narrative. The timeline accuracy was
assessed by comparing the gold standard results to the
CNTRO Timeline Library results. All conflicting results
between CNTRO and the gold standard were reviewed
among the human experts to determine if the conflict
resulted from an error in the gold standard result, an
error in manually annotations, or an error in the reason-
ing component of CNTRO.
CNTRO duration evaluation
Durations can be computed for an individual event, be-
tween two events, or between an event and a timestamp.
CNTRO first determines if ‘start’ and ‘end’ time infor-
mation exists for an event to calculate the duration. If
one of these pieces of information is missing, the pro-
gram then computes it by either using a duration anno-
tation, “Antiplatelet therapy was administered for two
months” (the antiplatelet therapy event is defined here
with a duration of 2 months) or uses a temporal relation
to another event with a relative time stamp, “Antiplatelet
therapy was started in May 2006. In July 2006, the pa-
tient underwent prostrate surgery. Antiplatelet therapy
was stopped the day before surgery”. In this secondexample the occurrence of antiplatelet therapy starting
and stopping each have a time stamp, and CNTRO in-
fers that antiplatelet therapy was administered for 2
months based on the duration between the start and end
times. In some cases, the duration of a pair of events
cannot be calculated directly (the two events are not dir-
ectly connected through the RDF graph), but need to go
through one or more intermediate events. In this case,
the above two functions need to be called iteratively
until the duration of the two events are calculated.
The adverse event narratives for late stent thrombosis
could describe durations in days, months, and/or years.
Month was the most frequent granularity used in the
complaint data, followed by years, and then days. To be
able to compare data from different narratives, the dur-
ation granularity was normalized to ‘Month’ for this use
case as this was the most frequently used granularity,
and estimating durations reported in years by number of
days would likely increase the noise within the data. The
durations calculated by CNTRO were compared to man-
ual calculations to determine accuracy.
Application of CNTRO temporal analysis
To provide an example of how the CNTRO system can
potentially be used to evaluate temporal properties
within narrative data, survival analysis was performed
using the narratives that specified both a duration of
Figure 4 Sample evaluation matrix (a) original document (partial); (b) event description; (c) asserted temporal relations; (d) asserted
and inferred temporal relations; (e) timeline bucket.
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late stent thrombosis (or in which a duration could be
inferred) to examine therapeutic guidelines for antiplate-
let administration duration. Note that as this data comes
from the FDA MAUDE Database, all records within the
example ended up with an event of late stent throm-
bosis. Data of patients who have not had a late stent
thrombosis occurrence are not easily accessible; there-
fore this example is purely illustrative of the CNTRO
system’s capability. Similarly, because the data used
within this analysis comes from adverse event files indi-
cating thrombosis occurred, no patient data requires
censoring.
Late Stent Thrombosis adverse event files were divided
into two different groups based on how long antiplatelet
therapy was administered in patients following implantationof a drug-eluting stent. Using current antiplatelet therapy
recommendations, any adverse event narrative specifying
that antiplatelet medication was administered for less than
6 months was segregated into the Shorter Duration of An-
tiplatelet Therapy group. Any adverse event narrative indi-
cating that antiplatelet medication was administered for 6
or more months was segregated into the Longer Duration
of Antiplatelet Therapy group. Adverse event narratives
that did not provide information specifying how long anti-
platelet therapy was prescribed were excluded from the
analysis.
Results
CNTRO timeline and duration evaluation
238 adverse event narratives included at least two events,
such that a timeline could be created within CNTRO for
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inferred timeline was evaluated with a gold standard result.
The CNTRO system was capable of correctly ordering
each event in all but 8 of the narratives. This resulted in
an overall CNTRO timeline accuracy of 95%. There were
41 adverse event narratives that included enough informa-
tion such that the duration of antiplatelet therapy was
known. The CNTRO automatic reasoning system had an
80% accuracy in inferring and/or calculating this duration
of an event. There were 77 adverse event narratives that
included enough information such that the duration be-
tween stent implantation and identification of late stent
thrombosis was known. The CNTRO Automatic reason-
ing system had a 76% accuracy in inferring and/or calcu-
lating this duration between events. An evaluation of the
errors and discussion of possible enhancements to the
CNTRO system is included within the Discussion section.
Late stent thrombosis adverse event temporal pattern
analysis
Within this paper, the CNTRO system was used to con-
firm what has been previously identified as a temporal
pattern within the late stent thrombosis adverse event in
a semi-automated manner, which is more efficient than
through manual observation. The common event pattern
within late stent thrombosis adverse events (stent im-
plantation, administration of antiplatelet therapy, discon-
tinuation of antiplatelet therapy, late stent thrombosis)
was shown by CNTRO system through timeline identifi-
cation of events. This result shows that the CNTRO sys-
tem has the potential to be applied across multiple
adverse event failure modes to identify new trends that
have previously not been observed.Figure 5 Survival analysis of shorter duration of antiplatelet therapy
late stent thrombosis adverse events.There were 36 adverse events that specified both the
duration between drug-eluting stent implantation and
occurrence of late stent thrombosis, and the duration of
antiplatelet therapy. These 36 reports were used to exe-
cute a survival analysis. Although this represents only a
limited subset of late stent thrombosis events and does
not include patient information for those who have not
had late stent thrombosis, the data can still be used for
illustration purposes of CNTRO’s temporal analysis cap-
abilities. Late Stent Thrombosis adverse event files were
divided into two different groups based on how long an-
tiplatelet therapy was administered in patients with an
implanted drug-eluting stent. Adverse event narratives
that did not provide information specifying how long an-
tiplatelet therapy was prescribed were excluded from the
analysis. 14 adverse events reported that antiplatelet
therapy was administered for 6 months or less following
initial stent implantation. 22 adverse events reported
that antiplatelet therapy was administered greater than 6
months.
Survival analysis with Kaplan-Meier curve and log-
rank test was performed in Minitab. The median time to
LST is 27.3 months for longer antiplatelet therapy group
and 14.6 months for shorter antiplatelet therapy group,
respectively. The p-value of log-rank test is 0.029, which
indicates a significant association between duration of
antiplatelet therapy and time to LST. Figure 5 supports
that on average, late stent thrombosis occurs later in pa-
tients who continued to take antiplatelet therapy longer
than 6 months. Although this is a retrospective observa-
tional study of a subset of LST cases only, the finding is
consistent and supports guidance for use of longer anti-
platelet therapy [1]. This example validates the CNTRO(group 1) and longer duration of antiplatelet therapy (group 2) in
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verify drug administration duration recommendations.
Discussion
Error analysis
Although the CNTRO system can provide relatively
good results for our use case, there are still limitations
in the system. First, the evaluation results work well with
the MAUDE reports because these reports are relatively
short and simple compared to other clinical narratives
such as clinical notes. Second, since the purpose of this
study is to evaluate CNTRO’s representation and reason-
ing capacities, the reports were annotated manually.
Many ambiguities and uncertainties were resolved dur-
ing the annotation process. Nevertheless, this study pro-
vides promising results and valuable analysis for us to
continue develop the CNTRO system.
The CNTRO system was able to order the event se-
quences for 95% of the narratives. The reasoner failed due
to different interpretations of time intervals and back-
ground assumptions in the manual annotation. Comput-
ing the order of two events is difficult when using ‘start’ or
‘finish’ temporal relations when both the start and end
times cannot be annotated. For example, a narrative might
specify that antiplatelet therapy began at the time of stent
implantation, and specify that it occurred for a period of 2
months. The temporal relation of the event1 (antiplatelet
therapy) and event2 (stent implantation) depends on
whether the start and end times of the events can be com-
pared. When considering the start time, the two events
start at the same time (event1 starts event2). The system
cannot infer the relationship by the end time since the
duration of “stent implantation” is not specified, given that
it occurs at a single point in time. Given the assumption
that the stent implantation procedure cannot last for 2
months, we can infer that event1 ends after event2. This
kind of background knowledge needs to be further speci-
fied in the domain ontology so that the CNTRO system
can infer the correct order. Additionally, “patient death”
inherently is known to be the last event in a patient-care
timeline. This kind of inherited order needs to be incorpo-
rated in the domain ontology so that the sequence of
events can be correctly inferred.
For duration inference, there are three major reasons
the program failed to return the correct results. (1) An-
notation ambiguities: some narratives contain duration
information in an ambiguous way such as in range (e.g.,
2-3 month), or in different levels of granularity (e.g.,
“two month and ten days”) that the program cannot
automatically process. We are working on expanding the
ontology so that it can cover ranges. In addition, we are
adding more functions to the reasoner so it can normalize
durations in different levels of granularity. (2) Long series
of events: sometimes the duration calculation involves along series of events. The program sometimes fails when
there are many intermediate events between the start and
the end events. This is usually due to one or more inter-
mediate events were not annotated by the ontology and
therefore were not included during the reasoning process.
3) Temporal relation granularity: an annotator can specify
the level of granularity over a temporal relation. For ex-
ample, we can specify that the granularity of “event1 be-
fore event2” is “day”. This means that the temporal
relation was compared on the granularity of day, which
implies that although event1 was before event2, but they
happened on the same day. This assumption was not pro-
grammed in the CNTRO reasoning system yet, and
caused errors when calculating the duration between
event1 and event3. For example, we know that Event3
may have occurred 183 days after event2, but without the
assumption that event1 and event2 happened on the same
day, the system cannot infer the duration between event1
and event3. The CNTRO reasoner needs to be updated to
handle level of granularity on temporal relations.
Areas for improvement of MAUDE database for temporal
analysis
There were some weaknesses identified regarding the
use of adverse event narratives from the MAUDE data-
base. The MAUDE database does not have selectable
fields for Device Manufacturer or Brand Name. Due to
the free text fields, there are a variety of spellings and
misspellings for both the Device Manufacturer and
Brand Name which may have resulted in a missed late
stent thrombotic adverse event based on how these
fields were used to sort complaints. The level of detail in
some adverse event narratives was very limited and the
duration between stent implantation and stent throm-
bosis may not have been documented. Additionally, due
to patient privacy some time stamps were removed mak-
ing the duration between stent implantation and stent
thrombosis unknown. It is possible that late stent throm-
bosis occurred in some patients but the complaint narra-
tives were filtered out due to not being able to classify the
event as “late.” Late stent thrombosis adverse events may
also have been missed while filtering from the files if a
different term was used within the narrative as there is
no searchable failure mode within MAUDE specific to
thrombosis.
Future CNTRO applications
Of interest in recent literature is a current investigation
into understanding whether there is a link between in-
complete stent apposition (ISA) (separation between the
stent strut and the vessel wall) and late stent thrombosis.
Stent which are not adequately apposed following im-
plantation are referred to as acute ISA, and may be due
to incorrect stent sizing or inadequate expansion of the
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point in time is referred to as late ISA. Late ISA can ei-
ther be persistent, meaning that it was the result of inad-
equate stent expansion, or acquired, meaning the vessel
becomes enlarged, or plaque or thrombosis in-between
the stent and wall dislodged creating space, or the stent
recoiled. There will likely be future studies attempting to
link late stent thrombosis with either persistent or ac-
quired ISA. The CNTRO system could be of value in
this investigation to determine if there is a correlation of
post-dilation frequency with late stent thrombosis or a
relationship between the change in apposition and the
duration between discontinuation of antiplatelet therapy
and thrombus formation.
Conclusion
Although the CNTRO system was able to provide rela-
tively good results for this use case, there are still limita-
tions in the system. First, the evaluation results work
well with the MAUDE reports because these reports are
relatively short and simple compared to other narratives
such as clinical notes. More CNTRO system evaluation
needs to be performed using complex electronic health
record data. Second, since the purpose of this study is to
evaluate CNTRO’s representation and reasoning capaci-
ties, the reports were annotated manually. The current
manual annotation method is not practical for long-term
use, and an automatic annotation process is currently
under development. Third, many ambiguities were re-
solved during the annotation process. Uncertainty rea-
soning is currently being incorporated into the CNTRO
system to resolve these ambiguities. In spite of these lim-
itations, this study provides promising results and valu-
able analysis to support continuing the development of
the CNTRO system.
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